CN107668695A - 一种预防心脑血管疾病的固体营养冲剂及其制备方法 - Google Patents
一种预防心脑血管疾病的固体营养冲剂及其制备方法 Download PDFInfo
- Publication number
- CN107668695A CN107668695A CN201710910883.3A CN201710910883A CN107668695A CN 107668695 A CN107668695 A CN 107668695A CN 201710910883 A CN201710910883 A CN 201710910883A CN 107668695 A CN107668695 A CN 107668695A
- Authority
- CN
- China
- Prior art keywords
- parts
- cerebrovascular disease
- solid nutritional
- raw material
- electuary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 35
- 239000007787 solid Substances 0.000 title claims abstract description 34
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 33
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 33
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 239000011575 calcium Substances 0.000 claims abstract description 21
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 21
- 244000068988 Glycine max Species 0.000 claims abstract description 15
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 15
- 230000002265 prevention Effects 0.000 claims abstract description 15
- 240000002234 Allium sativum Species 0.000 claims abstract description 14
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 14
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 14
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 14
- 235000003434 Sesamum indicum Nutrition 0.000 claims abstract description 14
- 240000003768 Solanum lycopersicum Species 0.000 claims abstract description 14
- 235000004611 garlic Nutrition 0.000 claims abstract description 14
- 235000005412 red sage Nutrition 0.000 claims abstract description 14
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 13
- 235000013311 vegetables Nutrition 0.000 claims abstract description 13
- 244000000231 Sesamum indicum Species 0.000 claims abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000036541 health Effects 0.000 abstract description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 235000008935 nutritious Nutrition 0.000 abstract description 6
- 239000011669 selenium Substances 0.000 abstract description 6
- 229910052711 selenium Inorganic materials 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 12
- 241000207961 Sesamum Species 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 235000001465 calcium Nutrition 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000005319 Sedum acre Species 0.000 description 1
- 235000014327 Sedum acre Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- -1 acyl monoethanolamine Chemical compound 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种预防心脑血管疾病的固体营养冲剂及其制备方法，由如下重量份数的原料制备得到：丹参25‑40份、黄大豆15‑25份、芝麻8‑15份、芦根5‑15份、大蒜5‑12份、西红柿5‑10份、高钙菜5‑10份、脱脂乳粉2‑5份。本发明制备的固体营养冲剂营养丰富、不含其他化学添加剂，安全无毒，能满足人体钙、硒等多元素的需求，很大程度上降低了影响人类健康的多种疾病的发生，具有活血通络、养心安神、延缓衰老的功效，对于心脑血管疾病的预防和辅助治疗有较好的效果，且本发明制作成本低，减轻了患者经济负担，还减轻了患者服药或手术时的痛苦。
Description
技术领域
本发明属于保健食品技术领域，更具体地，涉及一种预防心脑血管疾病的固体营养冲剂及其制备方法。
背景技术
心脑血管疾病是高脂血症、血液黏稠、动脉粥样硬化、高血压等导致心脑发生缺血性或出血性疾病的统称，具有“发病率高、致残率高、死亡率高、复发率高、并发症多”等特性。随着生活水平的提高和工作节奏的加快，心脑血管疾病的患病率逐年增加，而有些心脑血管疾病，如高血压因发病隐匿，因而被忽视，往往在健康体检时才发现。另外由于人们生活方式和膳食结构的明显转变，使得高血脂、高血压、高血糖、肥胖等愈加明显，这也是导致心脑血管疾病发生率持续上升的主要原因。一旦得上这类疾病，轻者需要长期吃药维持，重者需要花费大量的金钱去医院救治，给家庭造成很大的经济负担和心理压力。为了预防和治疗上述疾病，近年来有许多相关药品被不断开发，所谓是药三分毒，而且许多药物，不仅价钱昂贵，而且服用以后效果不明显。
发明内容
针对上述现有技术中的不足，本发明提供了一种预防心脑血管疾病的固体营养冲剂及其制备方法，制备工艺简单，疗效好，安全无副作用。
本发明的上述目的是通过以下技术方案予以实现的。
一种预防心脑血管疾病的固体营养冲剂，由如下重量份数的原料制备得到：丹参25-40份、黄大豆15-25份、芝麻8-15份、芦根5-15份、大蒜5-12份、西红柿5-10份、高钙菜5-10份、脱脂乳粉2-5份。
丹参：味苦，微寒，具有活血祛瘀，通经止痛，清心除烦，凉血消痈之功效。
黄大豆：含钙高，不含胆固醇，可以降低人体胆固醇，减少动脉硬化的发生，预防心脏病，黄大豆磷脂中含有85-90％磷脂酰胆碱以及鳞脂酰乙醇胺、磷脂糖甙等，能促进脂溶性维生素的吸收，防止体质及各组织器官酸化，还具有通导大便，降糖、降脂，增强机体免疫功能，防止血管硬化、预防心脏病等功效。
芝麻：富硒食物，含有大量蛋白质、膳食纤维、维生素、尼克酸、卵磷脂、亚油酸、钙、铁、镁等营养成分，具有补肝肾，益精血、调节胆固醇的作用，不仅能增强血管的弹性，还可促进血液循环，预防中老年心、脑血管硬化，可用于治疗身体虚弱、高血压、高血脂、身体虚弱等症。
芦根：性味甘，寒，营养丰富，味道芳香，具有清热去烦、安神的显著功效。适合于高血压、高血脂、动脉硬化、癌等病症的辅助治疗。
大蒜：含有丰富的蛋白质、脂肪、糖类、维生素及矿物质，具有预防血管老化、免疫力衰退等作用。具有降血压、减少血中胆固醇，以及抑制血液凝集的功效，因此对于动脉硬化及心脏疾病有预防的功能。
西红柿：富含维生素A、维生素C、维生素B1，维生素B2以及胡萝卜素和钙、磷、钾、镁、铁、锌、铜、硒和碘等多种元素，还含有蛋白质、糖类、有机酸、纤维素，具有降血压、降血脂、增加冠脉血流量等功能。
高钙菜：富含蛋白质、脂肪、碳水化合物、粗纤维和胡萝卜素、维生素b1、b2、维生素c及烟酸、钙、磷、铁等多种人体所需物质；更含有生物碱、齐墩果酸、谷甾醇、黄酮类、景天庚糖、果糖、蔗糖和有机酸等药用成份，有降血压血脂、活血化瘀、益气强心和宁心平肝、清热凉血的功能，并有减低苯丙胺的毒性和扩张冠状动脉的作用。
优选地，一种预防心脑血管疾病的固体营养冲剂，由如下重量份数的原料制备得到：丹参30-35份、黄大豆16-20份、芝麻10-12份、芦根8-10份、大蒜8-10份、西红柿6-8份、高钙菜6-8份、脱脂乳粉3-4份。
本发明还提供所述的一种预防心脑血管疾病的固体营养冲剂的制备方法，包括如下步骤：
S1.将选好的丹参、黄大豆、芝麻、芦根、大蒜、西红柿、高钙菜、脱脂乳粉分别称好备用；
S2.将步骤S1中的各原料分别清洗干净，晾干；
S3.将经过步骤S2处理的各组分原料按比例混合后，送入粉碎机中搅拌混合制粉，过筛；
S4.将经过步骤S3处理的粉末料烘干、杀菌得粉末状固体成品；
优选地，所述的一种预防心脑血管疾病的固体营养冲剂的制备方法，步骤S3中将粉末过20目筛，通过20目筛的原料进入步骤S4，不能通过20目筛的原料重复步骤S4。
优选地，所述的一种预防心脑血管疾病的固体营养冲剂的制备方法，步骤S4中烘干温度控制在45～55℃， 干燥至含水量低于5％。
优选地，所述的一种预防心脑血管疾病的固体营养冲剂的制备方法，步骤S4中采用紫外线照射15min杀菌。
所述的一种预防心脑血管疾病的固体营养冲剂的剂型为粉剂、颗粒剂中的任意一种。
与现有技术相比，本发明有益效果在于：本发明通过上述配方合理配伍，制备的固体营养冲剂营养丰富、不含其他化学添加剂，安全无毒，能满足人体钙、硒等多元素的需求，很大程度上降低了影响人类健康的多种疾病的发生，具有活血通络、养心安神、延缓衰老的功效，对于心脑血管疾病的预防和辅助治疗有较好的效果，且本发明制作成本低，减轻了患者经济负担，还减轻了患者服药或手术时的痛苦。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白，以下结合实施例，对本发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅仅用以解释本发明，并不用于限定本发明。除非特别说明，本发明采用的试剂、方法和设备为本技术领域常规试剂、方法和设备。
作为一种优选的实施方式，一种富硒高钙营养代餐粉的制备方法，包括如下步骤：
S1.将选好的丹参、黄大豆、芝麻、芦根、大蒜、西红柿、高钙菜、脱脂乳粉分别称好备用；
S2.将步骤S1中的各原料分别清洗干净，晾干；
S3.将经过步骤S2处理的各组分原料按比例混合后，送入粉碎机中搅拌混合制粉，过筛；
S4.将经过步骤S3处理的粉末料烘干、杀菌得粉末状固体成品；
更优选地，所述的一种预防心脑血管疾病的固体营养冲剂的制备方法，步骤S3中将粉末过20目筛，通过20目筛的原料进入步骤S4，不能通过20目筛的原料重复步骤S4；步骤S4中烘干温度控制在45～55℃， 干燥至含水量低于5％，采用紫外线照射15min杀菌。
实施例1～4以上述优选的制备方法进行富硒高钙营养代餐粉的制备。
具体实施方式中的一种预防心脑血管疾病的固体营养冲剂的剂型为粉剂、颗粒剂中的任意一种。
以下以具体实施条件为例对本发明方法进行进一步说明。
实施例1
一种预防心脑血管疾病的固体营养冲剂，由如下重量份数的原料制备得到：丹参30份、黄大豆20份、芝麻12份、芦根10份、大蒜8份、西红柿8份、高钙菜8份、脱脂乳粉3份。
实施例2
一种预防心脑血管疾病的固体营养冲剂，由如下重量份数的原料制备得到：丹参35份、黄大豆16份、芝麻10份、芦根8份、大蒜10份、西红柿6份、高钙菜6份、脱脂乳粉4份。
实施例3
一种预防心脑血管疾病的固体营养冲剂，由如下重量份数的原料制备得到：丹参25份、黄大豆15份、芝麻8份、芦根5份、大蒜5份、西红柿5份、高钙菜5份、脱脂乳粉2份。
实施例4
一种预防心脑血管疾病的固体营养冲剂，由如下重量份数的原料制备得到：丹参40份、黄大豆25份、芝麻15份、芦根15份、大蒜12份、西红柿10份、高钙菜10份、脱脂乳粉5份。
对比例1
一种预防心脑血管疾病的固体营养冲剂，由如下重量份数的原料制备得到：丹参22份、黄大豆28份、芝麻6份、芦根18份、大蒜15份、西红柿2份、高钙菜12份、脱脂乳粉6份。
对比例2
一种预防心脑血管疾病的固体营养冲剂的配方与实施例1相同，不同之处在于制备方法步骤S4中烘干温度控制在65℃， 干燥至含水量低于5％，其余与实施例1相同。
应用例
随机抽取年龄在50-60岁之间患有高血压、高血脂、静脉血栓等心脑血管系统疾病患者共300人，分为6组，每组50人，分别饮用实施例1～4及对比例1～2的固体营养冲剂，以热水冲服，替代每日晚餐，坚持每天服用3个月，疗效判定标准：①显效：血压、血脂正常、血栓消除、身体健康；②好转：血压、血脂较之前降低、血栓部分消除；③无效：血压、血脂、血栓较之前无改善。调查结果如下表所示：
| 患者数量/例 | 显效/例 | 好转/例 | 无效/例 | 有效率/％ | |
| 实施例1 | 50 | 48 | 2 | 0 | 100 |
| 实施例2 | 50 | 46 | 4 | 0 | 100 |
| 实施例3 | 50 | 45 | 5 | 0 | 100 |
| 实施例4 | 50 | 43 | 7 | 0 | 100 |
| 对比例1 | 50 | 38 | 7 | 5 | 90 |
| 对比例2 | 50 | 35 | 8 | 7 | 86 |
本发明通过优化配方合理配伍，制备的固体营养冲剂营养丰富，具有活血通络的功效，能够有效预防和治疗高血压、高血脂、消除血栓，对于心脑血管疾病的预防和辅助治疗有较好的效果，能够减轻心脑血管系统疾病患者的痛苦，改善中老年身体状况，起到保健作用，且本发明不含其他化学添加剂，安全无毒、操作简便、运行可靠、生产效益高，能满足人类的养生保健需求，市场应用前景广泛。
以上所述，仅为本发明的说明实施例，并非对本发明任何形式上和实质上的限制，应当指出，对于本技术领域的普通技术人员，在不脱离本发明方法的前提下，做出的若干改进和补充也应视为本发明的保护范围。凡熟悉本专业的技术人员，在不脱离本发明精神和范围的情况下，利用以上所揭示的技术内容做出的些许更改、修饰与演变的等同变化，均为本发明的等效实施例；同时，凡依据本发明的实质技术对上述实施例所做的任何等同变化的更改、修饰与演变，均仍属于本发明的保护范围。
Claims (7)
1.一种预防心脑血管疾病的固体营养冲剂，其特征在于，由如下重量份数的原料制备得到：丹参25-40份、黄大豆15-25份、芝麻8-15份、芦根5-15份、大蒜5-12份、西红柿5-10份、高钙菜5-10份、脱脂乳粉2-5份。
2.根据权利要求1所述的一种预防心脑血管疾病的固体营养冲剂，其特征在于，由如下重量份数的原料制备得到：丹参30-35份、黄大豆16-20份、芝麻10-12份、芦根8-10份、大蒜8-10份、西红柿6-8份、高钙菜6-8份、脱脂乳粉3-4份。
3.权利要求1或2所述的一种预防心脑血管疾病的固体营养冲剂的制备方法，其特征在于，包括如下步骤：
S1.将选好的丹参、黄大豆、芝麻、芦根、大蒜、西红柿、高钙菜、脱脂乳粉分别称好备用；
S2.将步骤S1中的各原料分别清洗干净，晾干；
S3.将经过步骤S2处理的各组分原料按比例混合后，送入粉碎机中搅拌混合制粉，过筛；
S4.将经过步骤S3处理的粉末料烘干、杀菌得粉末状固体成品。
4.根据权利要求3所述的一种预防心脑血管疾病的固体营养冲剂的制备方法，其特征在于，步骤S3中将粉末过20目筛，通过20目筛的原料进入步骤S4，不能通过20目筛的原料重复步骤S4。
5.根据权利要求3所述的一种预防心脑血管疾病的固体营养冲剂的制备方法，其特征在于，步骤S4中烘干温度控制在45～55℃， 干燥至含水量低于5％。
6.根据权利要求3所述的一种预防心脑血管疾病的固体营养冲剂的制备方法，其特征在于，步骤S4中采用紫外线照射15min杀菌。
7.根据权利要求1所述的一种预防心脑血管疾病的固体营养冲剂，所述固体营养冲剂的剂型为粉剂、颗粒剂中的任意一种。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710910883.3A CN107668695A (zh) | 2017-09-29 | 2017-09-29 | 一种预防心脑血管疾病的固体营养冲剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710910883.3A CN107668695A (zh) | 2017-09-29 | 2017-09-29 | 一种预防心脑血管疾病的固体营养冲剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107668695A true CN107668695A (zh) | 2018-02-09 |
Family
ID=61138354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710910883.3A Pending CN107668695A (zh) | 2017-09-29 | 2017-09-29 | 一种预防心脑血管疾病的固体营养冲剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107668695A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110447843A (zh) * | 2019-09-19 | 2019-11-15 | 盐亭县良永生猪养殖专业合作社 | 一种功能性高钙菜肉脯的加工方法 |
| CN111298074A (zh) * | 2018-12-11 | 2020-06-19 | 山东理工大学 | 一种预防和改善冠心病的心脏保护类的植物草药制剂 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709147A (zh) * | 2005-07-06 | 2005-12-21 | 郑弘� | 救心菜干粉 |
-
2017
- 2017-09-29 CN CN201710910883.3A patent/CN107668695A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709147A (zh) * | 2005-07-06 | 2005-12-21 | 郑弘� | 救心菜干粉 |
Non-Patent Citations (4)
| Title |
|---|
| 唐书同: "《生活知识百科 1》", 31 October 2009, 吉林大学出版社 * |
| 桂常青等: "《健康是"磨"出来的》", 30 November 2009, 广东科技出版社 * |
| 郝建新等: "《中国药膳学》", 28 February 2007, 科学技术文献出版社 * |
| 韦彦芝等: "《中华药膳防治肾脏疾病》", 30 November 2000, 科学技术文献出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111298074A (zh) * | 2018-12-11 | 2020-06-19 | 山东理工大学 | 一种预防和改善冠心病的心脏保护类的植物草药制剂 |
| CN110447843A (zh) * | 2019-09-19 | 2019-11-15 | 盐亭县良永生猪养殖专业合作社 | 一种功能性高钙菜肉脯的加工方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103099089B (zh) | 一种降糖、降压、通便减肥、抗疲劳、改善性功能保健品及其生产工艺 | |
| CN106858620A (zh) | 一种贫血专用型临床营养配方及其制备方法 | |
| Kumar et al. | Traditional medicinal uses and therapeutic benefits of Momordica charantia Linn | |
| CN107319525A (zh) | 一种减肥减脂专用型临床营养配方及其制备方法 | |
| CN104799146A (zh) | 一种改善亚健康的功能性营养食品组合及其制备方法 | |
| CN108013454A (zh) | 妇科炎症专用型临床营养配方及其制备方法 | |
| CN108112973A (zh) | 一种辅助降三高组合物及其制备方法 | |
| CN104922550A (zh) | 一种中药组合物及其应用 | |
| CN102178183A (zh) | 一种五豆综合营养食品 | |
| CN107373672A (zh) | 一种月经不调女性专用型临床营养配方及其制备方法 | |
| CN105106754A (zh) | 一种食疗抗癌制剂及其制备方法 | |
| CN111149968A (zh) | 一种健康固体饮料及其制备方法 | |
| DE60129282T2 (de) | Heilnahrungsmittel | |
| CN111771988A (zh) | 适用于糖尿病人食用的营养食品及其制备方法 | |
| CN104187681B (zh) | 一种降血糖降血脂保健食品及其制备方法 | |
| CN107668695A (zh) | 一种预防心脑血管疾病的固体营养冲剂及其制备方法 | |
| WO2022016773A1 (zh) | 有助于养胃、护胃的组合物及其制备方法 | |
| RU2533040C2 (ru) | Состав для приготовления фитоджема (варианты) | |
| CN105341704A (zh) | 一种黑糖红豆沙 | |
| CN104970220A (zh) | 一种哺乳期母猪配合饲料及其制备方法 | |
| CN108478714A (zh) | 一种儿科自闭症康复治疗辅助用中药组合物 | |
| CN106822684A (zh) | 防治高尿酸血症的中药组合物、药物及其制备方法和应用 | |
| CN107212402B (zh) | 降血压食品及其制备方法 | |
| CN111407850A (zh) | 植物硒黄精片及其制备方法 | |
| CN103798596A (zh) | 一种供心脑血管疾病患者食用的全营养配方食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180209 |